The Clinical Practice Guidelines for Cervical Screening in Aotearoa New Zealand 2023 have been developed for practitioners providing health services across the cervical screening pathway.
These guidelines are intended for use by clinicians and health professionals working in primary health care and Districts that provide health care services to NBSP participants. The guidelines describe best clinical practices and consist of systematically developed recommendations designed to assist clinicians and participants in shared decision-making.
These guidelines are for health practitioners providing antenatal care in Aotearoa New Zealand. Health practitioners should use it to support clinical judgement, knowledge and expertise and provide for a timely, consistent, and effective approach to offering and providing antenatal screening for Down syndrome and other conditions.
These guidelines are for all practitioners involved in aspects of the Newborn Metabolic Screening Programme (NMSP), including Lead Maternity Carers (LMCs), hospital midwives, nurses and phlebotomists.